Novo Nordisk launches international survey into the psychosocial effects of living with haemophilia
- Details
- Category: Novo Nordisk

Long-term efficacy and tolerability of Vimpat® (lacosamide)
- Details
- Category: Clinical Trials
UCB's antiepileptic drug (AED) Vimpat® (lacosamide) featured in several studies and analyses presented at the 62nd annual American Academy of Neurology (AAN) meeting. These data offer additional clinical evidence supporting the use of lacosamide as adjunctive therapy in the treatment of adult patients with partial-onset seizures.
Stemgent and Pfizer Announce Collaboration
- Details
- Category: Pfizer

Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market
- Details
- Category: Roche

Additional Alemtuzumab Mechanism of Action Data Reported
- Details
- Category: Genzyme

A potential first-in-class, once-daily oral therapy for relapsing forms of multiple sclerosis
- Details
- Category: Novartis

Sanofi-aventis and CureDM Sign Exclusive Worldwide License Agreement
- Details
- Category: Sanofi

More Pharma News ...
- Nycomed and Baxter receive FDA approval for TachoSil®
- Novel agent Lu AE04621 enters Lundbeck's development pipeline
- Boehringer Ingelheim launches Global Venture Fund to foster innovation in life sciences
- GSK and Isis Pharmaceuticals collaborate on RNA therapeutics
- Pfizer Posts Details About Interactions With U.S. Physicians
- Novo Nordisk Introduces New Industry Resource for Information on Diabetes and Chronic Disease
- Lilly USA Updates Health Education Program to Help Patients with Depression Build Network of Support